Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Completed

A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

NCT01920061

Conditions
Breast Diseases, Breast Neoplasms, Neoplasm, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Hematology Oncology Los Angeles, California, United States
View all 29 locations
View Trial Details
Completed

A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)

NCT03232593

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +27 more
Locations
  • Dongnam Inst.of Radiological & Medical Sciences Busan, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
  • Inje university Haeundae Paik Hospital Busan, South Korea
  • Dong-A University Hospital Busan, South Korea
View all 56 locations
View Trial Details
Completed

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

NCT02404441

Conditions
Anaplastic Thyroid Cancer, Breast Diseases, Breast Neoplasms, +27 more
Locations
  • The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Johns Hopkins Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Oregon Health and Science University SC-10 Portland, Oregon, United States
  • Sarah Cannon Research Institute SCRI RC Nashville, Tennessee, United States
View all 41 locations
View Trial Details
Completed

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

NCT02071862

Conditions
Adenocarcinoma, Adenoma, Breast Diseases, +38 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute of Emory School of Medicine Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)

NCT02425891

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Kaiser Permanente of Northern California Oakland, California, United States
  • Emad Ibrahim, Md, Inc Redlands, California, United States
View all 247 locations
View Trial Details

Related conditions